# Ondansetron

NDC: 68788-4133
Generic name: Ondansetron
Labeler / Manufacturer: Preferred Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20260611

FDA application: ANDA078152

## Active ingredients

- ONDANSETRON: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68788-4133"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68788-4133
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e87a5803-e872-43f7-8a15-79aa236e8c07